THE DEFINITIVE GUIDE TO 4F-MDMB K2 INFUSED PAPER

(b) If The chief commissioner establishes a plan beneath this subchapter, the commissioner shall publish a report not afterwards than January 1 of every odd-numbered calendar year about the clinical effectiveness of the usage of tetrahydrocannabinols and their derivatives and any other professional medical conclusions in the analysis program.(a-1)